Revel Pharmaceuticals Email Format
Biotechnology ResearchCalifornia, United States2-10 Employees
Revel Pharmaceuticals is a biotechnology company focused on developing therapeutic enzymes intended to address damage from aging by degrading Advanced Glycation End Products (AGEs), long-lived protein modifications implicated in several aging-related diseases. By targeting these pathological age-associated compounds, the company aims to provide potential treatments that could apply across multiple indications, reflecting a positioning within the broader aging and longevity therapeutics space. The business is based in San Francisco, California, and operates with a small team. Revel Pharmaceuticals’ work centers on translating the concept of repairing age-related molecular damage into product candidates that address unmet needs in aging-associated disease biology.